Invention Grant
- Patent Title: Antibodies to PCSK9 and uses thereof
- Patent Title (中): PCSK9的抗体及其用途
-
Application No.: US13611196Application Date: 2012-09-12
-
Publication No.: US08530414B2Publication Date: 2013-09-10
- Inventor: Julian Davies , Ryan James Darling , Barrett Allan
- Applicant: Julian Davies , Ryan James Darling , Barrett Allan
- Applicant Address: US IN Indianapolis
- Assignee: Eli Lilly and Company
- Current Assignee: Eli Lilly and Company
- Current Assignee Address: US IN Indianapolis
- Agent Alexander Wilson
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K39/395 ; A61K39/00 ; C12P21/08 ; C07K16/00
Abstract:
The present invention relates to antibodies to proprotein convertase subtilisin/kexin type 9 (PCSK9), or antigen-binding fragments thereof, compositions comprising such PCSK9 antibodies or antigen-binding fragments, and methods of using the same for the treatment of hyperlipidemia or hypercholesterolemia.
Public/Granted literature
- US20130071405A1 ANTIBODIES TO PCSK9 AND USES THEREOF Public/Granted day:2013-03-21
Information query
IPC分类:
